K. Mori

The Activation of Type 1 and Type 2 Plasminogen by Type I and Type II Tissue Plasminogen Activator (*)

R. Dwek, A. Downing, G. Opdenakker, 1995, The Journal of Biological Chemistry.

Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter

S. Madoiwa, J. Mimuro, Y. Sakata, 2001, Gene Therapy.

Effect of carbohydrate side chain of tissue-type plasminogen activator on its interaction with plasminogen activator inhibitor-1

S. Madoiwa, J. Mimuro, Y. Sakata, 1998 .

The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia

Y. Sakata, M. Matsuda, K. Mori, 1991 .

The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.

Y. Sakata, M. Matsuda, K. Mori, 1991, Blood.

Effect of glycosidase inhibitors on the biosynthesis of alpha 2-plasmin inhibitor and antithrombin III in Hep G2 cells.

J. Mimuro, Y. Sakata, M. Matsuda, 1994, Biochimica et biophysica acta.

Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase

A. Tanaka, A. Kaji, K. Mori, 1995, Antimicrobial agents and chemotherapy.